Analyst Moves: ABBV, RRC, HRL - Presented by: The Aol. On Network

This morning, BMO Capital increased its EPS estimates on shares of AbbVie (ABBV) through 2014 as the company's pipeline of new products continues to advance. In the report, BMO raised its price target to $48 while maintaining its market perform rating.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.75 0.02 ▲ 0.12%
AAPL $ 132.54 1.15 ▲ 0.88%
ONTY $ 3.01 0.50 ▲ 19.92%
HPQ $ 34.76 0.93 ▲ 2.75%
PBR $ 9.15 0.34 ▼ 3.58%
T $ 34.71 0.36 ▼ 1.03%
MSFT $ 46.90 0.52 ▼ 1.10%
F $ 15.27 0.24 ▼ 1.55%

As of 5/22/2015, 04:15 PM

Latest News Headlines

View All Latest Headlines